KLF2 and hypercalcemia disease: To sum up, the present study demonstrates that silencing OGT decreases the expression of histone methylase EZH2, thereby upregulating KLF2 and then downregulating the expression of CXCL1, which alleviates hypercalcemia-induced nerve injury in renal failure (Fig. 7).